KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Equity Ratio (2016 - 2025)

AbbVie (ABBV) has disclosed Equity Ratio for 14 consecutive years, with 0.02 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 145.86% to 0.02 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.02, a 145.86% decrease, with the full-year FY2024 number at 0.02, down 68.13% from a year prior.
  • Equity Ratio was 0.02 for Q3 2025 at AbbVie, down from 0.01 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.12 in Q4 2022 to a low of 0.02 in Q3 2025.
  • A 5-year average of 0.07 and a median of 0.09 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 212.23% in 2021, then crashed 145.86% in 2025.
  • AbbVie's Equity Ratio stood at 0.11 in 2021, then rose by 18.22% to 0.12 in 2022, then plummeted by 38.03% to 0.08 in 2023, then tumbled by 68.13% to 0.02 in 2024, then plummeted by 178.9% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Equity Ratio are 0.02 (Q3 2025), 0.01 (Q1 2025), and 0.02 (Q4 2024).